Hostname: page-component-5d59c44645-klj7v Total loading time: 0 Render date: 2024-02-20T17:10:12.436Z Has data issue: false hasContentIssue false

Can Antidepressants Act as Potential Pro-neoplastic Agents in Patients with Neurotrophic Factor-Related Cancers?

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]


Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Copyright © Cambridge University Press 2008



1.Massie, MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:5771.CrossRefGoogle Scholar
2.Chaturvedi, S, Maguire, P, Hopwood, P. Antidepressant medications in cancer patients. Psycho-Oncology. 1994;3:5760.CrossRefGoogle Scholar
3.Dias, BG, Banerjee, SB, Duman, RS, Vaidya, VA. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology. 2003;5:553563.CrossRefGoogle Scholar
4.Nibuya, M, Morinobu, S, Duman, RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:75397547.CrossRefGoogle ScholarPubMed
5.Ivy, AS, Rodriguez, FG, Garcia, C, Chen, MJ, Russo-Neustadt, AA. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav. 2003;75:8188.CrossRefGoogle ScholarPubMed
6.Coppell, AL, Pei, Q, Zetterstrom, TSC. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003;44:903910.CrossRefGoogle ScholarPubMed
7.Saarelainen, T, Hendolin, P, Lucas, G, et al.Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant induced behavioral effects. J Neurosci. 2003;23:349357.CrossRefGoogle ScholarPubMed
8.Chen, B, Dowlatshahi, D, MacQueen, GM, Wang, JF, Young, LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry. 2001;50:260265.CrossRefGoogle ScholarPubMed
9.Sartor, L, Negro, A, Barletta, E, Mugnai, G, Garbisa, S. Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: relation to invasion. Clin Exp Metastasis. 2002;19:709716.CrossRefGoogle Scholar
10.Middlemas, DS, Kihl, BK, Moody, NM. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol. 1999;45:2736.CrossRefGoogle ScholarPubMed
11.Jaboin, J, Kim, CJ, Kaplan, DR, Thiele, CJ. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res. 2002;62:67566763.Google ScholarPubMed
12.Warner-Schmidt, JL, Duman, RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A. 2007;104:46474652.CrossRefGoogle ScholarPubMed
13.McMahon, G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000;5(suppl 1):310.CrossRefGoogle ScholarPubMed
14.Brandes, LJ, Arron, RJ, Bogdanovic, RP, et al.Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res. 1992;52:37963800.Google ScholarPubMed